Shareholding disclosure

NEWRON PHARMCEUTICALS SPA

Declared position

18.343%

Threshold

Crossed downwards

Timeline

Published

21.03.2024

Transaction

14.03.2024

Voting rights breakdown

Voting rights acquired0%

Voting rights sold18.343%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

ZA01-000000000O3P1

Beneficial owner

NEWRON PHARMCEUTICALS SPA

Declared address

NEWRON PHARMCEUTICALS SPA, BRESSO (MILAN), IT

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

NEWRON PHARMCEUTICALS SPA

Newron Pharmaceuticals S.p.A.21.03.2024ZA01-000000000O3P1

Disclosure summary

NEWRON PHARMCEUTICALS SPA disclosed a holding in Newron Pharmaceuticals S.p.A. on the disposal side, published by SIX Exchange Regulation on 21.03.2024, at 18.343% of voting rights. Notice category: Single shareholder.

Disclosed position

18.343%

Voting rights sold

Voting rights acquired0%

Voting rights sold18.343%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

NEWRON PHARMCEUTICALS SPA disclosed a holding in Newron Pharmaceuticals S.p.A., published on 21.03.2024.

Publication date21.03.2024

Transaction date14.03.2024

Issuing companyNewron Pharmaceuticals S.p.A.

Beneficial ownerNEWRON PHARMCEUTICALS SPA

Declared addressNEWRON PHARMCEUTICALS SPA, BRESSO (MILAN), IT

CategorySingle shareholder

Voting rights acquired0%

Voting rights sold18.343%

Below threshold0%

ExchangeXSWX

Notification IDZA01-000000000O3P1

Source: SIX Exchange Regulation · Publication date: 21.03.2024

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open